XML 245 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest
Beginning of period (in shares) at Mar. 31, 2022     164,372,545          
Beginning of period at Mar. 31, 2022 $ 1,046,721   $ 1,646 $ (1,635,454) $ 656,222 $ 2,015,071 $ 8,585 $ 651
Beginning of period (in shares) at Mar. 31, 2022       (31,788,197)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     385,009          
Issuance of common stock 6,081   $ 3   6,078      
Stock options exercised (in shares)     143,325          
Stock options exercised 4,596   $ 1   4,595      
Repurchase of common stock (in shares)   (600,000)   (689,304) [1]        
Repurchase of common stock (57,558) [1] $ (46,900)   $ (57,558) [1]        
Net income 138,093         138,284   (191)
Other comprehensive income, net of tax 5,757           5,757  
Dividends declared (58,262)         (58,262)    
Stock-based compensation expense 13,696       13,696      
Contribution to non-controlling interest 0       (959)     959
End of period (in shares) at Jun. 30, 2022     164,900,879          
End of period at Jun. 30, 2022 $ 1,099,124   $ 1,650 $ (1,693,012) 679,632 2,095,093 14,342 1,419
End of period (in shares) at Jun. 30, 2022       (32,477,501)        
Beginning of period (in shares) at Mar. 31, 2023 131,637,588   165,872,332          
Beginning of period at Mar. 31, 2023 $ 992,002   $ 1,659 $ (1,859,905) 769,460 2,051,455 29,333 0
Beginning of period (in shares) at Mar. 31, 2023 (34,234,744)     (34,234,744)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     396,569          
Issuance of common stock $ 6,925   $ 4   6,921      
Stock options exercised (in shares)     252,382          
Stock options exercised 11,176   $ 2   11,174      
Repurchase of common stock (in shares)   (1,000,000)   (1,170,169) [2]        
Repurchase of common stock (112,981) [2] $ (100,100)   $ (112,981) [2]        
Net income 161,388         161,388   0
Other comprehensive income, net of tax 3,358           3,358  
Dividends declared (62,482)         (62,482)    
Stock-based compensation expense $ 17,685       17,685      
End of period (in shares) at Jun. 30, 2023 131,116,370   166,521,283          
End of period at Jun. 30, 2023 $ 1,017,071   $ 1,665 $ (1,972,886) $ 805,240 $ 2,150,361 $ 32,691 $ 0
End of period (in shares) at Jun. 30, 2023 (35,404,913)     (35,404,913)        
[1] During the three months ended June 30, 2022, the Company purchased 0.6 million shares of the Company’s Class A Common Stock in a series of open market transactions for $46.9 million. Additionally, the Company repurchased shares for $10.6 million during the three months ended June 30, 2022 to cover the minimum statutory withholding taxes on restricted stock units that vested on various dates during the period.
[2] During the three months ended June 30, 2023, the Company purchased 1.0 million shares of the Company’s Class A Common Stock in a series of open market transactions for $100.1 million. Additionally, the Company repurchased shares for $12.4 million during the three months ended June 30, 2023 to cover the minimum statutory withholding taxes on restricted stock units that vested on various dates during the period.